中药育发洗剂治疗雄激素性秃发的疗效及安全性评价

王爱娟, 胡慧, 冯放, 罗莎, 杨知山, 侯宗楠, 杨顶权

王爱娟, 胡慧, 冯放, 罗莎, 杨知山, 侯宗楠, 杨顶权. 中药育发洗剂治疗雄激素性秃发的疗效及安全性评价[J]. 实用临床医药杂志, 2021, 25(5): 45-49. DOI: 10.7619/jcmp.20201376
引用本文: 王爱娟, 胡慧, 冯放, 罗莎, 杨知山, 侯宗楠, 杨顶权. 中药育发洗剂治疗雄激素性秃发的疗效及安全性评价[J]. 实用临床医药杂志, 2021, 25(5): 45-49. DOI: 10.7619/jcmp.20201376
WANG Aijuan, HU Hui, FENG Fang, LUO Sha, YANG Zhishan, HOU Zongnan, YANG Dingquan. Evaluation in effects of traditional Chinese medicine named Yufa Lotion in the treatment of androgenic alopecia[J]. Journal of Clinical Medicine in Practice, 2021, 25(5): 45-49. DOI: 10.7619/jcmp.20201376
Citation: WANG Aijuan, HU Hui, FENG Fang, LUO Sha, YANG Zhishan, HOU Zongnan, YANG Dingquan. Evaluation in effects of traditional Chinese medicine named Yufa Lotion in the treatment of androgenic alopecia[J]. Journal of Clinical Medicine in Practice, 2021, 25(5): 45-49. DOI: 10.7619/jcmp.20201376

中药育发洗剂治疗雄激素性秃发的疗效及安全性评价

基金项目: 

国家自然科学基金项目 81973691

首都卫生发展科研专项 首发2016-3-4064

详细信息
    通讯作者:

    杨顶权, E-mail: ydqlx@163.com

  • 中图分类号: R758.71;R445.9

Evaluation in effects of traditional Chinese medicine named Yufa Lotion in the treatment of androgenic alopecia

  • 摘要:
      目的  结合临床症状与毛发镜征象评价中药育发洗剂治疗雄激素性秃发(AGA)的疗效及安全性。
      方法  将56例AGA患者通过抽签方式随机分为观察组39例与对照组17例。观察组给予中药育发洗剂外用治疗,对照组给予空白洗剂外用治疗,2组患者均连续使用相应洗剂6个月。比较治疗前后3个固定观察区(额角、百会、发旋)毛发镜下的客观指标(总毛干数、毛干直径变异数量、毛干直径变异比值、头皮炎症)以及临床主观症状积分(头皮瘙痒、头皮油脂分泌、头皮屑),分析中药育发洗剂对AGA的治疗效果;比较2组不良反应发生率,评价中药育发洗剂治疗AGA的安全性。
      结果  治疗后,观察组左额角毛干直径变异比值、百会毛干直径变异数、百会毛干直径变异比值均低于治疗前,差异有统计学意义(P < 0.05)。治疗后,对照组左额角、百会、发旋部位的总毛干数、毛干直径变异数、毛干直径变异比值与治疗前比较,差异均无统计学意义(P>0.05)。治疗后,观察组头皮炎症和头皮瘙痒、头皮油脂分泌的治疗有效率均高于对照组,差异有统计学意义(P < 0.05)。2组患者治疗期间均未发生不良反应。
      结论  中药育发洗剂治疗AGA能减少毛干直径变异数量,降低毛干直径变异比值,显著改善头皮炎症、缓解瘙痒、减少头皮油脂分泌,且使用方便安全,无明显不良反应发生。
    Abstract:
      Objective  To observe the efficacy and safety of traditional Chinese medicine named Yufa Lotion in the treatment of androgenic alopecia(AGA)by combining the clinical symptoms and trichoscopy system.
      Methods  A total of 56 patients with AGA were randomly divided into observation group(n=39)and control group(n=17) according to lottery method. The observation group was given topical treatment with traditional Chinese medicine named Yufa Lotion, and the control group was given a blank lotion for external use. Both groups used the corresponding lotion continuously for 6 months. The objective indicators(total hair shaft count, hair shaft diameter variation, hair shaft diameter variation rate, scalp inflammation) under trichoscopy in three fixed observation areas (frontal angle, Baihui, and hairpin) before and after 3 months of treatment, clinical subjective symptoms integral (scalp itching, scalp oil secretion, dandruff) were compared, the therapeutic effects of traditional Chinese medicine named Yufa Lotion in the treatment of AGA were analyzed, and the safety of traditional Chinese medicine named Yufa Lotion in the treatment of AGA was evaluated. The incidence of adverse reactions of two groups was compared.
      Results  After treatment, the observation group was significantly better than the control group in terms of variation ratio of hair shaft diameter in left frontal angle forehead, the number of hair shaft diameter variation in Baihui and the variation ratio of hair shaft diameter in Baihui of the observation group were significantly lower than before treatment (P < 0.05). The total number of hair shafts, the number of hair shaft diameter variations, and the hair shaft diameter variation ratio of the left frontal angle, Baihui, and hairpin showed no significant differences compared with those before treatment (P>0.05). After treatment, the effective rates of scalp inflammation, scalp itching and scalp oil secretion in the observation group were higher than those in the control group, and the differences were statistically significant (P < 0.05). There were no adverse reactions in the observation group and the control group during the treatment period.
      Conclusion  The treatment of AGA with traditional Chinese medicine named Yufa Lotion can reduce the number of hair shaft diameter variation, decrease the hair shaft diameter variation ratio, significantly improve scalp inflammation, relieve itching, reduce scalp oil secretion. Besides, it is convenient and safe, and has no obvious adverse reactions.
  • 表  1   2组治疗前后毛发镜征象指标水平比较(x ±s)

    组别 指标 左额角 百会 发旋
    治疗前 治疗后 治疗前 治疗后 治疗前 治疗后
    对照组(n=17) 毛干直径变异数/根 39.82±4.57 38.88±4.04 22.59±4.36 22.41±3.77 15.88±3.04 17.41±3.96
    毛干总数/根 51.88±3.48 48.12±3.26 60.29±2.54 61.94±2.38 62.88±2.04 62.24±2.89
    毛干直径变异比值 0.74±0.05 0.78±0.04 0.37±0.07 0.37±0.06 0.25±0.05 0.27±0.06
    观察组(n=39) 毛干直径变异数/根 24.21±2.54 21.15±2.58 16.56±1.84 12.82±1.16* 12.54±1.18 12.67±1.36
    毛干总数/根 38.92±2.28 39.90±2.17 53.21±1.98 54.31±2.20 56.23±1.97 59.08±2.73
    毛干直径变异比值 0.58±0.04 0.49±0.05* 0.31±0.04 0.24±0.02* 0.22±0.02 0.21±0.02
    与治疗前比较, *P < 0.05。
    下载: 导出CSV

    表  2   2组头皮炎症疗效比较[n(%)]

    组别 治疗前后头皮炎症积分差 总有效
    -2分 -1分 0分 1分 2分
    对照组(n=17) 4(23.53) 3(17.65) 10(58.82) 0 0 10(58.82)
    观察组(n=39) 0 4(10.26) 23(58.97) 11(28.21) 1(2.56) 35(89.74)*
    与对照组比较, *P < 0.05。
    下载: 导出CSV

    表  3   2组治疗后临床主观症状疗效比较[n(%)]

    组别 症状 治疗前后临床主观症状积分差 总有效
    -2分 -1分 0分 1分 2分
    对照组(n=17) 头皮瘙痒 6(35.29) 6(35.29) 4(23.53) 1(5.88) 0 5(29.41)
    头皮油脂分泌 4(23.53) 4(23.53) 9(52.94) 0 0 9(52.94)
    头皮屑 5(29.41) 8(47.06) 3(17.65) 1(5.88) 0 4(23.53)
    观察组(n=39) 头皮瘙痒 1(2.56) 4(10.26) 29(74.36) 5(12.82) 0 34(87.18)*
    头皮油脂分泌 2(5.13) 10(25.64) 18(46.15) 9(23.08) 0 27(69.23)*
    头皮屑 3(7.69) 26(66.67) 8(20.51) 2(5.13) 0 10(25.64)
    与对照组比较, *P < 0.05。
    下载: 导出CSV
  • [1] 中华医学会皮肤性病学分会毛发学组. 中国雄激素性秃发诊疗指南[J]. 临床皮肤科杂志, 2014, 43(3): 182-186. https://www.cnki.com.cn/Article/CJFDTOTAL-LCPF201403029.htm
    [2]

    KANTI V, MESSENGER A, DOBOS G, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men-short version[J]. J Eur Acad Dermatol Venereol, 2018, 32(1): 11-22. doi: 10.1111/jdv.14624

    [3]

    TSUBOI R, ITAMI S, INUI S, et al. Guidelines for the management of androgenetic alopecia(2010)[J]. J Dermatol, 2012, 39(2): 113-120. doi: 10.1111/j.1346-8138.2011.01361.x

    [4]

    RANGWALA S, RASHID R M. Alopecia: A review of laser and light therapies[J]. Dermatol Online J, 2012, 18(2): 3-3. http://med.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_PM22398224

    [5]

    TRAISH A M. Post-finasteride syndrome: a surmountable challenge for clinicians[J]. Fertil Steril, 2020, 113(1): 21-50. doi: 10.1016/j.fertnstert.2019.11.030

    [6]

    PALLOTTI F, SENOFONTE G, PELLONI M, et al. Androgenetic alopecia: effects of oral finasteride on hormone profile, reproduction and sexual function[J]. Endocrine, 2020, 68(3): 688-694. doi: 10.1007/s12020-020-02219-2

    [7]

    GOTTLIEB T B, KATZ F H, CHIDSEY C A. Combined therapy with vasodilator drugs and beta-adrenergic blockade in hypertension. A comparative study of minoxidil and hydralazine[J]. Circulation, 1972, 45(3): 571-582. doi: 10.1161/01.CIR.45.3.571

    [8] 赵辨. 中国临床皮肤病学[M]. 南京: 江苏科学技术出版社, 2010: 701-703.
    [9]

    LEE W S, RO B I, HONG S P, et al. A new classification of pattern hair loss that is universal for men and women: basic and specific (BASP) classification[J]. J Am Acad Dermatol, 2007, 57(1): 37-46. doi: 10.1016/j.jaad.2006.12.029

    [10]

    MUBKI T, RUDNICKA L, OLSZEWSKA M, et al. Evaluation and diagnosis of the hair loss patient: part Ⅱ. Trichoscopic and laboratory evaluations[J]. J Am Acad Dermatol, 2014, 71(3): 431. e1-431. e11. doi: 10.1016/j.jaad.2014.05.008

    [11]

    NYHOLT D R, GILLESPIE N A, HEATH A C, et al. Genetic basis of male pattern baldness[J]. J Invest Dermatol, 2003, 121(6): 1561-1564. doi: 10.1111/j.1523-1747.2003.12615.x

    [12]

    NORWOOD O T. Male pattern baldness: classification and incidence[J]. South Med J, 1975, 68(11): 1359-1365. doi: 10.1097/00007611-197511000-00009

    [13]

    WANG T L, ZHOU C, SHEN Y W, et al. Prevalence of androgenetic alopecia in China: a community-based study in six cities[J]. Br J Dermatol, 2010, 162(4): 843-847. doi: 10.1111/j.1365-2133.2010.09640.x

    [14]

    XU F, SHENG Y Y, MU Z L, et al. Prevalence and types of androgenetic alopecia in Shanghai, China: a community-based study[J]. Br J Dermatol, 2009, 160(3): 629-632. doi: 10.1111/j.1365-2133.2008.08909.x

    [15]

    ANITUA E, PINO A, MARTINEZ N, et al. The effect of plasma rich in growth factors on pattern hair loss: a pilot study[J]. Dermatol Surg, 2017, 43(5): 658-670. doi: 10.1097/DSS.0000000000001049

    [16] 项晶, 苏莹莹, 范建国, 等. 针刺联合低能量激光治疗雄激素性秃发疗效观察[J]. 上海针灸杂志, 2020, 39(2): 188-191. https://www.cnki.com.cn/Article/CJFDTOTAL-SHZJ202002014.htm
    [17] 刘涛, 李志武, 丁街生, 等. A型肉毒素治疗雄激素源性脱发的临床观察[J]. 中山大学学报: 医学版, 2018, 39(3): 467-471. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSYK201803023.htm
    [18] 魏盛, 朱敏刚, 王音, 等. 纳晶微针联合米诺地尔酊治疗男性雄激素性秃发的临床疗效[J]. 中华医学美学美容杂志, 2020, 26(5): 372-374. http://med.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_zhyxmr202005004
    [19] 占钻, 曹春水, 江娟, 等. 复方丹参注射液对大鼠心肺复苏后凝血功能及血液流变学的影响[J]. 重庆医学, 2019, 48(15): 2524-2527. doi: 10.3969/j.issn.1671-8348.2019.15.002
    [20]

    JIN J, HU Q Y, XU W W, et al. Tanshinone ⅡA attenuates estradiol-induced polycystic ovarian syndrome in mice by ameliorating FSHR expression in the ovary[J]. Exp Ther Med, 2019, 17(5): 3501-3508. http://www.ncbi.nlm.nih.gov/pubmed/30988730

    [21]

    ROH S S, KIM C D, LEE M H, et al. The hair growth promoting effect of Sophora flavescens extract and its molecular regulation[J]. J Dermatol Sci, 2002, 30(1): 43-49. doi: 10.1016/S0923-1811(02)00060-9

    [22] 姚艺新, 华芳, 洪远林, 等. 川芎药材、饮片及其中成药抗血小板聚集活性的生物检定方法学研究[J]. 中草药, 2017, 48(11): 2249-2254. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYO201711016.htm
    [23]

    LI Y, HAN M, LIN P, et al. Hair growth promotion activity and its mechanism of Polygonum multiflorum[J]. Evid Based Complement Alternat Med, 2015, 2015: 517901. http://europepmc.org/articles/PMC4534627

    [24] 张春洪. 生发酊对C57BL/6小鼠毛发生长作用的实验研究[D]. 咸阳: 陕西中医药大学, 2010.
    [25] 林桂涛, 李荣伟, 耿子凯, 等. 补骨脂水及乙醇提取物雌激素样作用的比较[J]. 中成药, 2016, 38(12): 2688-2691. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYA201612034.htm
    [26] 关波, 皇甫俊茹, 徐媛, 等. 不同促透剂对根皮素体外透皮吸收的影响[J]. 中国医药导报, 2019, 16(32): 4-8. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY201932002.htm
    [27]

    KIBAR M, AKTAN S, BILGIN M. Scalp dermatoscopic findings in androgenetic alopecia and their relations with disease severity[J]. Ann Dermatol, 2014, 26(4): 478-484. doi: 10.5021/ad.2014.26.4.478

    [28] 徐宇轩, 范卫新. 雄激素受体与雄激素性秃发相关性研究进展[J]. 临床皮肤科杂志, 2019, 48(9): 572-577. https://www.cnki.com.cn/Article/CJFDTOTAL-LCPF201909021.htm
表(3)
计量
  • 文章访问数:  494
  • HTML全文浏览量:  285
  • PDF下载量:  36
  • 被引次数: 0
出版历程
  • 收稿日期:  2020-11-07
  • 网络出版日期:  2021-03-22
  • 发布日期:  2021-03-14

目录

    /

    返回文章
    返回
    x 关闭 永久关闭